Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-01-25

FDA Approved: PREZCOBIX — Supplemental Application (Janssen Products, LP)

View source ↗

Summary

The FDA approved a supplemental application for PREZCOBIX (darunavir ethanolate and cobicistat) submitted by Janssen Products, LP, likely modifying labeling or …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PREZCOBIX (darunavir ethanolate and cobicistat)

Snippet

SUPPL AP for PREZCOBIX (DARUNAVIR ETHANOLATE AND COBICISTAT)